<i>In vitro</i>susceptibility of<i>Mycobacterium abscessus</i>complex and feasibility of standardizing treatment regimens

Abstract

In vitro activity was demonstrated for clofazimine, bedaquiline and eravacycline, indicating potential for inclusion as standardized therapy for M. abscessus complex infections.